Filing Details

Accession Number:
0001628280-24-009764
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-07 19:51:40
Reporting Period:
2024-03-06
Accepted Time:
2024-03-07 19:51:40
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1588978 Procept Biorobotics Corp PRCT Surgical & Medical Instruments & Apparatus (3841) 260199180
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1653771 Kevin Waters C/O Procept Biorobotics Corporation
150 Baytech Drive
San Jose CA 95134
Evp, Cfo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-03-06 19,328 $0.00 52,851 No 4 A Direct
Common Stock Disposition 2024-03-06 3,435 $46.67 49,416 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2024-03-06 16,835 $0.00 16,835 $47.17
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,835 2034-03-05 No 4 A Direct
Footnotes
  1. These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. 1/4th of the RSUs shall vest on the anniversary of the vesting commencement date of March 5, 2024, and annually over a three year period thereafter, subject to continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.
  2. These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on February 16, 2023.
  3. The price reported in Column 4 is a weighted average price.
  4. 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2024 over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date.